Back
AnaptysBio Vs. DXP Enterprises Industry Stock Comparison
Sell
2
ANAB
AnaptysBio
Last Price:
21.56
Seasonality Move:
1.79%
Buy
65
DXPE
DXP Enterprises
Last Price:
65.66
Seasonality Move:
39.89%
Sell
2
AnaptysBio (ANAB)
is a Sell
Is AnaptysBio a Buy, Sell or Hold?
- The current AnaptysBio [ANAB] share price is $19.88. The Score for ANAB is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
- ANAB is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
65
DXP Enterprises (DXPE)
is a Buy
Is DXP Enterprises a Buy, Sell or Hold?
- The current DXP Enterprises [DXPE] share price is $61.59. The Score for DXPE is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- DXPE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ANAB Stock Price Chart
What is AnaptysBio's stock price today?
-
The AnaptysBio share price today is $19.88
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ANAB is experiencing buying pressure, which is a positive indicator for future bullish movement.
DXPE Stock Price Chart
What is DXP Enterprises's stock price today?
-
The DXP Enterprises share price today is $61.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DXPE is experiencing buying pressure, which is a positive indicator for future bullish movement.
ANAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.54 | Sell |
| Relative Strength Index (14 RSI): | 19.36 | Sell |
| Chaikin Money Flow: | 395227 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.82 - 36.16) | Sell |
| Bollinger Bands (100): | (27.12 - 37.36) | Sell |
DXPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.37 | Buy |
| Relative Strength Index (14 RSI): | 75.92 | Buy |
| Chaikin Money Flow: | 171896 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49 - 54.5) | Buy |
| Bollinger Bands (100): | (47.11 - 53.29) | Buy |
ANAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.83 | Sell |
| 20-day SMA: | 30.14 | Sell |
| 50-day SMA: | 33.61 | Sell |
| 200-day SMA: | 27.9 | Sell |
| 8-day EMA: | 24.07 | Sell |
| 20-day EMA: | 28.48 | Sell |
| 50-day EMA: | 31.49 | Sell |
| 200-day EMA: | 28.68 | Sell |
DXPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.15 | Buy |
| 20-day SMA: | 51.64 | Buy |
| 50-day SMA: | 51.78 | Buy |
| 200-day SMA: | 47.83 | Buy |
| 8-day EMA: | 52.64 | Buy |
| 20-day EMA: | 51.7 | Buy |
| 50-day EMA: | 51.38 | Buy |
| 200-day EMA: | 47.37 | Buy |
AnaptysBio Earnings Growth & ANAB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.57 per share, and a decrease next year of $0.25 per share.
DXP Enterprises Earnings Growth & DXPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.30 per share.
AnaptysBio Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
DXP Enterprises Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||